Literature DB >> 9627664

Prospective randomized comparison of external dacryocystorhinostomy and endonasal laser dacryocystorhinostomy.

J Hartikainen1, R Grenman, P Puukka, H Seppä.   

Abstract

OBJECTIVE AND
DESIGN: The introduction of endonasal laser dacryocystorhinostomy (ENL-DCR) in the early 1990s showed great promise of changing dacryocystorhinostomy into an elegant, minimally invasive procedure from the traditional external dacryocystorhinostomy (EXT-DCR). This prospective, randomized study compares these two operations, their success rates, surgical durations, and postoperative symptoms. PARTICIPANTS: A total of 64 cases in 61 patients with primary acquired nasolacrimal sac or duct obstruction were divided into 2 subgroups by symptoms (simple epiphora and chronic dacryocystitis). These patients were randomized within both subgroups into 2 operation groups with 32 cases in each group. INTERVENTION: Altogether, 32 EXT-DCRs and 32 ENL-DCRs were performed. The silicone tube was removed at 6 months after surgery. The final follow-up visit was at 1 year after surgery. The patency of the lacrimal passage was investigated by irrigation, and patients were questioned about their symptoms. MAIN OUTCOME MEASURES: The patency of the lacrimal passage to irrigation and the duration of surgery were measured.
RESULTS: The success rate at 1 year after surgery was 91% for EXT-DCR and 63% for ENL-DCR after primary surgery. The difference was statistically significant (P = 0.016). The surgical duration for ENL-DCR was three times shorter than for EXT-DCR, the average duration being 23 minutes and 78 minutes, respectively (P < 0.0001).
CONCLUSIONS: The EXT-DCR, when compared with ENL-DCR, seems to provide superior operation results in primary acquired nasolacrimal duct obstruction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627664     DOI: 10.1016/S0161-6420(98)96015-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  40 in total

1.  Endolacrimal laser assisted lacrimal surgery.

Authors:  K Muellner; E Bodner; G E Mannor; G Wolf; T Hofmann; W Luxenberger
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Dacryocystorhinostomy: History, evolution and future directions.

Authors:  Vladimir S Yakopson; Joseph C Flanagan; Daniel Ahn; Betsy P Luo
Journal:  Saudi J Ophthalmol       Date:  2010-10-18

3.  Safety and efficacy of adjunctive intranasal mitomycin C and triamcinolone in endonasal endoscopic dacryocystorhinostomy.

Authors:  Emmy Y Li; Andy C Cheng; Alex C Wong; Amy M Sze; Hunter K Yuen
Journal:  Int Ophthalmol       Date:  2015-05-26       Impact factor: 2.031

Review 4.  [Diagnosis and treatment of the watering eye].

Authors:  M Schargus; G Geerling
Journal:  HNO       Date:  2017-01       Impact factor: 1.284

5.  Balloon dacryoplasty: ushering the new and routine era in minimally invasive lacrimal surgeries.

Authors:  Mohammad Javed Ali; Milind N Naik; Santosh G Honavar
Journal:  Int Ophthalmol       Date:  2012-10-17       Impact factor: 2.031

6.  Intranasal endoscopic DCR (END-DCR) in cases of dacryocystitis.

Authors:  Mangal Singh; Vimal Jain; S C Gupta; S P Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2004-07

7.  Endoscopic vs external dacryocystorhinostomy-comparison from the patients' aspect.

Authors:  Serdar Ozer; Pinar A Ozer
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

8.  Endoscopic DCR: How To Improve The Results.

Authors:  Satya Prakash Dubey; Vishal Rattan Munjal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-02-04

9.  Office-based endoscopic revision using a microdebrider for failed endoscopic dacryocystorhinostomy.

Authors:  Jongyeop Park; Hochang Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-24       Impact factor: 2.503

10.  External versus endonasal dacryocystorhinostomy in a specialized lacrimal surgery center.

Authors:  Vinod Gauba
Journal:  Saudi J Ophthalmol       Date:  2013-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.